panchakarma疗法在bala(免疫)预防和治疗COVID-19方面的综述

Vedpathak S, B. V., Tanwar V
{"title":"panchakarma疗法在bala(免疫)预防和治疗COVID-19方面的综述","authors":"Vedpathak S, B. V., Tanwar V","doi":"10.46607/iamj3408112020","DOIUrl":null,"url":null,"abstract":"Introduction: Worldwide prevalence rate of COVID-19 is increasing day wise, and estimated at 6.6% in the Indian population in August 2020, the curable medicine and immunization for COVID-19 is not availa-ble yet. The disease COVID-19 can be compared with Janapadodhansa Vyadhi (Epidemic) mentioned in Ayurveda. Panchakarma therapies are advised in Janapadodhansa Vyadhi. Virus is very prominent, and it is the common cause mentioned in both. The Ayurved fraternity and people have fear about Panchakarma therapies in the COVID-19 era. Aim: need of current situation is to find applicability effectiveness of Pan-chakarma therapies. Methodology: By critical literary search of Classical Ayurvedic texts, electronic me-dia, PubMed, indexed Journal, Google scholar is carried out and observations were recorded. Observation and Results: Panchakarma helps to increase Bala (Immunity) and improves immunomodulation effect of Rasayana (Rejuvenation) medicine. Fever, Headache, Common cold, Cough, Dyspnea, these are common symptoms found in COVID-19 and Panchakarma therapies are indicated in the same. Conclusion: Pan-chakarma Therapies, are independently advocated for improvement of Bala (Immunity) and as a preopera-tive measure for improving immunomodulation property of Rasayana (Rejuvenation) medicines. These principles of Panchakarma Therapies can be applied in prevention and treatment of COVID- 19 disease.","PeriodicalId":277149,"journal":{"name":"November 2020","volume":"3 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2020-11-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"A REVIEW OF PANCHAKARMA THERAPIES WITH RESPECT TO BALA \\n(IMMUNITY) FOR PREVENTION AND MANAGEMENT OF COVID-19\",\"authors\":\"Vedpathak S, B. V., Tanwar V\",\"doi\":\"10.46607/iamj3408112020\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Introduction: Worldwide prevalence rate of COVID-19 is increasing day wise, and estimated at 6.6% in the Indian population in August 2020, the curable medicine and immunization for COVID-19 is not availa-ble yet. The disease COVID-19 can be compared with Janapadodhansa Vyadhi (Epidemic) mentioned in Ayurveda. Panchakarma therapies are advised in Janapadodhansa Vyadhi. Virus is very prominent, and it is the common cause mentioned in both. The Ayurved fraternity and people have fear about Panchakarma therapies in the COVID-19 era. Aim: need of current situation is to find applicability effectiveness of Pan-chakarma therapies. Methodology: By critical literary search of Classical Ayurvedic texts, electronic me-dia, PubMed, indexed Journal, Google scholar is carried out and observations were recorded. Observation and Results: Panchakarma helps to increase Bala (Immunity) and improves immunomodulation effect of Rasayana (Rejuvenation) medicine. Fever, Headache, Common cold, Cough, Dyspnea, these are common symptoms found in COVID-19 and Panchakarma therapies are indicated in the same. Conclusion: Pan-chakarma Therapies, are independently advocated for improvement of Bala (Immunity) and as a preopera-tive measure for improving immunomodulation property of Rasayana (Rejuvenation) medicines. These principles of Panchakarma Therapies can be applied in prevention and treatment of COVID- 19 disease.\",\"PeriodicalId\":277149,\"journal\":{\"name\":\"November 2020\",\"volume\":\"3 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2020-11-18\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"November 2020\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.46607/iamj3408112020\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"November 2020","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.46607/iamj3408112020","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

摘要

导言:2019冠状病毒病的全球患病率日益上升,据估计,2020年8月印度人口的患病率为6.6%,但目前还没有针对COVID-19的可治愈药物和免疫接种。COVID-19可以与阿育吠陀中提到的Janapadodhansa Vyadhi(流行病)进行比较。Panchakarma疗法建议在Janapadodhansa Vyadhi。病毒是非常突出的,它是两者中提到的共同原因。在新冠肺炎时代,印度的兄弟会和民众对Panchakarma疗法感到恐惧。目的:寻找泛脉疗法的适用性和有效性是当前的需要。方法:通过对经典阿育吠陀文本、电子媒体、PubMed、索引期刊、Google scholar进行批判性文献检索,并记录观察结果。观察与结果:Panchakarma有助于提高Bala(免疫),提高Rasayana(回春)药物的免疫调节作用。发烧、头痛、普通感冒、咳嗽、呼吸困难,这些都是COVID-19的常见症状,Panchakarma疗法也适用于此。结论:泛脉轮疗法是一种独立提倡的改善Bala(免疫)和改善Rasayana(返青)药物免疫调节特性的术前措施。Panchakarma疗法的这些原理可以应用于COVID- 19疾病的预防和治疗。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
A REVIEW OF PANCHAKARMA THERAPIES WITH RESPECT TO BALA (IMMUNITY) FOR PREVENTION AND MANAGEMENT OF COVID-19
Introduction: Worldwide prevalence rate of COVID-19 is increasing day wise, and estimated at 6.6% in the Indian population in August 2020, the curable medicine and immunization for COVID-19 is not availa-ble yet. The disease COVID-19 can be compared with Janapadodhansa Vyadhi (Epidemic) mentioned in Ayurveda. Panchakarma therapies are advised in Janapadodhansa Vyadhi. Virus is very prominent, and it is the common cause mentioned in both. The Ayurved fraternity and people have fear about Panchakarma therapies in the COVID-19 era. Aim: need of current situation is to find applicability effectiveness of Pan-chakarma therapies. Methodology: By critical literary search of Classical Ayurvedic texts, electronic me-dia, PubMed, indexed Journal, Google scholar is carried out and observations were recorded. Observation and Results: Panchakarma helps to increase Bala (Immunity) and improves immunomodulation effect of Rasayana (Rejuvenation) medicine. Fever, Headache, Common cold, Cough, Dyspnea, these are common symptoms found in COVID-19 and Panchakarma therapies are indicated in the same. Conclusion: Pan-chakarma Therapies, are independently advocated for improvement of Bala (Immunity) and as a preopera-tive measure for improving immunomodulation property of Rasayana (Rejuvenation) medicines. These principles of Panchakarma Therapies can be applied in prevention and treatment of COVID- 19 disease.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Multifunctional barrier coating systems created by multilayer curtain coating Pigmented aqueous barrier coatings The use of hollow sphere pigments as strength additives in paper and paperboard coatings—Part 1: The predictive nature of packing models on coating properties Numerical analysis of slot die coating of nanocellulosic materials The use of hollow sphere pigments as strength additives in paper and paperboard coatings—Part 2: Optimization in paperboard formulations for opacity and strength
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1